Results 31 to 40 of about 335,217 (205)

A description of skeletal manifestation in adult case of morquio syndrome: radiographic and MRI appearance. [PDF]

open access: yesCase Rep Med, 2012
We report on a rare case of Morquio syndrome, an autosomal recessive mucopolysaccharidosis including type IVA, a deficiency of N-acetylgalctosamine-6-sulfatase and type IVB a deficiency of β-galactosidase.
Di Cesare A   +5 more
europepmc   +2 more sources

Morquio syndrome (MPV IV)-A case report

open access: yesIndian Journal of Ophthalmology, 1991
A child, of normal intelligence, belonging to a nonconsanguineous marriage was diagnosed as MPS type IV the so called Morquio syndrome. Despite mild corneal cloudiness no other ophthalmological abnormalities were observed.
Rekhi Gulbir
doaj   +2 more sources

Phenotype-Genotype Correlation in Morquio A Syndrome: Protocol for a Meta-Analysis.

open access: yesJMIR Res Protoc
BackgroundMucopolysaccharidosis type IVA (MPS IVA), also known as Morquio A syndrome, is a rare lysosomal storage disease characterized by autosomal recessive inheritance of mutations in the N-acetylgalactosamine-6-sulfatase ...
Diaz-Ordoñez L   +5 more
europepmc   +2 more sources

Overcoming the barriers to diagnosis of Morquio A syndrome [PDF]

open access: yesOrphanet Journal of Rare Diseases, 2014
Morquio A syndrome is an autosomal recessive lysosomal storage disease often resulting in life-threatening complications. Early recognition and proficient diagnosis is imperative to facilitate prompt treatment and prevention of clinical complications.Experts in Asia Pacific reviewed medical records focusing on presenting signs and symptoms leading to a
Adeline Tan   +20 more
core   +4 more sources

Characterization of a novel exonic deletion in the GALNS gene causing Morquio A syndrome

open access: yesMolecular Genetics and Metabolism Reports, 2022
Mucopolysaccharidosis IVA or Morquio A syndrome is a rare lysosomal storage disorder caused by N-acetylgalactosamine-6-sulfatase deficiency. A diagnosis can be provided by the identification of reduced N-acetylgalactosamine-6-sulfatase activity as well ...
Kathryn DeLong   +4 more
doaj   +1 more source

Therapies of mucopolysaccharidosis IVA (Morquio A syndrome) [PDF]

open access: yesExpert Opinion on Orphan Drugs, 2013
Morquio A syndrome (mucopolysaccharidosis type IVA, MPS IVA) is one of the lysosomal storage diseases and is caused by the deficiency of N-acetylgalactosamine-6-sulfate sulfatase (GALNS). Deficiency of this enzyme leads to accumulation of glycosaminoglycans (GAGs), keratan sulfate (KS) and chondroitin-6-sulfate (C6S).
Shunji, Tomatsu   +11 more
openaire   +2 more sources

Mucopolysaccharidosis IVA: Diagnosis, Treatment, and Management. [PDF]

open access: yes, 2020
Mucopolysaccharidosis type IVA (MPS IVA, or Morquio syndrome type A) is an inherited metabolic lysosomal disease caused by the deficiency of the N-acetylglucosamine-6-sulfate sulfatase enzyme.
Couce, Maria L.   +6 more
core   +2 more sources

Activity of daily living for Morquio A syndrome [PDF]

open access: yesMolecular Genetics and Metabolism, 2016
The aim of this study was to evaluate the activity of daily living (ADL) and surgical interventions in patients with mucopolysaccharidosis IVA (MPS IVA). The factor(s) that affect ADL are age, clinical phenotypes, surgical interventions, therapeutic effect, and body mass index.
Eriko, Yasuda   +24 more
openaire   +2 more sources

Trends in Serum Cytokine Expression in Pediatric Skeletal Dysplasia

open access: yesJBMR Plus, Volume 7, Issue 12, December 2023., 2023
We identified differences in cytokine expression in multiple types of pediatric skeletal dysplasia as compared to typically growing children. Four of the 12 analyzed cytokines demonstrated elevated expression above control levels in all of the dysplasia cohorts (IL‐12, IL‐13, IP‐10, RANTES) and 2 demonstrated expression below control levels across all ...
David A. O'Connell   +6 more
wiley   +1 more source

Modeling Morquio A Syndrome: An Anthropometric Study of Body Characteristics and Stature

open access: yesDiagnostics, 2020
Background: Morquio A syndrome or mucopolysaccharidosis (MPS) IVA is an autosomal recessive, life-limiting lysosomal storage disease caused by deficient activity of the enzyme galactosamine-6-sulfatase. Common early symptoms such as abnormalities of body
Agnieszka Różdżyńska-Świątkowska   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy